Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Search for 5-HT2C ligands at Organon leads to the full agonist Org-38457

Sep. 18, 1998

Stilbene analogue of pranlukast is a potent LTD4 antagonist with improved pharmacokinetics

Sep. 18, 1998

RPR-132703: a second-generation PDE4 inhibitor from Rhone-Roulenc Rorer

Sep. 18, 1998

Selective and sensitive p38 MAP kinase inhibitor identified by SmithKline Beecham

Sep. 18, 1998

Astra describes SAR leading to antithrombotic agent with novel mechanism of action

Sep. 18, 1998

Pharmacological characterization of new Astra agent for airways diseases presented at EFMC

Sep. 18, 1998

New treatment for BPH discovered by Hungarian research team

Sep. 17, 1998

GW-273227, a sodium channel blocker for the treatment of pain

Sep. 17, 1998

First group 1 mGluR antagonist with submicromolar potency described by Lilly

Sep. 17, 1998

Organon discovers new pharmacophore providing potent, orally active thrombin inhibitors

Sep. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...